Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-14 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2025-02-11 | Amended | $417,380 | $417,380 | Equity Only | 06b | SEC link |
| 2023-10-11 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2023-01-26 | Amended | $1,490,435 | $402,742 | Equity Only | 06b | SEC link |
| 2022-01-14 | Amended | $1,087,693 | $459,806 | Equity Only | 06b | SEC link |
| 2021-02-01 | Amended | $627,887 | $364,118 | Equity Only | 06b | SEC link |
| 2020-01-31 | Amended | $263,769 | $263,769 | Equity Only | 06b | SEC link |
| 2019-02-27 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2017-11-17 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2016-11-16 | Amended | $887,000 | $687,000 | Equity Only | 06b | SEC link |
| 2016-02-29 | New | $200,000 | $200,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| W. Kendall Brown | Director |
| Walter Kendall Brown | Director |
| Benjamin F Cravatt | Director |
| Mark G. Currie | Director |
| Nabil Elkouh | Director |
| Michael J. Higgins | Director |
| Eduardo J. Martinez | Executive |
| Eric R Olson | Director |
| James P. Pearson | Director, Executive |
| Shaker Sadasivam | Director |
| Anne M. Sullivan | Executive |